Home/Turn Therapeutics/Dr. Neil Ghodadra, MD
DN

Dr. Neil Ghodadra, MD

Chief Medical Officer, Board Director

Turn Therapeutics

Turn Therapeutics Pipeline

DrugIndicationPhase
GX-03Moderate-to-Severe Atopic Dermatitis (Eczema)Phase 1
Hexagen™ Wound DressingWound Care & Infection PreventionCommercial
Thermostable Vaccine InitiativeGlobal Health / Infectious DiseaseResearch